January 31, 2017

Currently valued at $200 billion, it is expected to reach $413.8 billion worldwide by end of 2026. 

January 31, 2017

Sunshine State News is reporting that U.S. Reps. Gus Bilirakis, R-Fla., and Kurt Schrader, D-Ore., have introduced the Lower Drug Costs Through Competition Act, which is aimed at encouraging generics makers to develop generics of products with little or no competition, or for drugs that are in short supply. The bill calls for the creation of a Priority Review Voucher for generics applications filed for drugs that have no current competition. The bill was referred to the House Energy and Commerce Committee Monday, and eight representatives have signed on. (Sunshine State News)

January 26, 2017

FDA determines Dalfampridine Extended-Release tablets, 10 mg is bioequivalent to Amprya.

January 25, 2017
The drug had U.S. sales of $204 million for the 12 months ended September 2016, according to QuintilesIMS data. 
January 24, 2017
The drug is indicated to treat plaque psoriasis in patients 18 years of age or older and had sales estimated at $24 million for the 12 months ended November 2016, the company said. 
January 23, 2017

FamilyWize’s Medicine Cabinet allows users to create a personal profile and easily find the lowest price for their prescriptions through FamilyWize’s website and mobile app. 

January 20, 2017

The drug is indicated to treat hypertension and had a market size of $81.9 million for the 12 months ended November 2016, according to QuintilesIMS data.  

January 19, 2017

The drug has an estimated market size of $117 million for the 12 months ended November 2016, according to QuintilesIMS. 

January 19, 2017

Citron Research's analysis notes that Lannett is highly leveraged and dependent on three drugs for a bulk of its sales and that even modest price cuts to its biggest sellers would cause it to violate its debt covenants. 

January 18, 2017

The study found that retrospective rebates, discounts and fees have increased from $67 billion in 2013 to $106 billion in 2015. 

January 17, 2017

For the fourth consecutive year, NCPA asked its members to rank legislative priorities. For the 115th Congress, the top three concerns are DIR fees, generic pricing transparency and any willing provider provision.

January 17, 2017

The publication of the draft guidance means that stakeholders can now comment for 60 days after Jan. 18 in order for comments to be considered before the final version of the guidance is written

January 17, 2017
According to QuintilesIMS data, brand and generic sales for 100-mg strength amiodarone tablets were $23 million for the 12 months ended November 2016. 
January 12, 2017

Two-pack of generic carries a $109.99 price tag.

January 11, 2017

The drug is indicated to treat certain types of seizures in patients older than 13 years of age. 

January 10, 2017

The Philadelphia Inquirer is reporting that Heritage Pharmaceuticals’s former CEO and chairman, Jeffrey Glazer, and former SVP commercial operations, Jason Malek, admitted in federal court that between April 2013 and December 2015, they worked together to manipulate prices of  Heritage’s generics of doxycycline hyclate and glyburide. The two face up to 10 years in prison each. After the two were indicted 20 states filed suit against six generics companies, including Heritage. (Philadelphia Inquirer)

January 10, 2017
The transaction is part of the European Commission’s antitrust divestiture requirements surrounding Teva’s acquisition of Allergan’s generics business. 
January 10, 2017

The drug is indicated to treat and prevent influenza A and as a treatment for parkinsonism and drug-induced extrapyramidal reactions. 

January 6, 2017
The drug is indicated to treat or prevent bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease. 
January 4, 2017

Sandoz‘s generic will be available in 40-, 80- and 125-mg dosage strengths.

January 3, 2017

The Food and Drug Administration approved three generics from New Jersey-based specialty generics company Teligent on the last day of 2016, the company announced Tuesday.

January 3, 2017

Lupin in the last week of 2016 received tentative approval for its generics of Benicar tablets, Giazo tablets and Livalo tablets. 

January 3, 2017

The company on Thursday announced the launch of its generics of Concerta extended-release tablets, Zovia tablets and Cerebyx injection. 

December 21, 2016

Walgreens has expanded the availability of prescription-free naloxone to 33 states and the District of Columbia.